| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
At the heart of it, blood unifies
|
The Lancet Haematology,
|
|
2015
|
2 |
9 |
p. e347-
1 p.
|
artikel
|
| 2 |
Conditioning regimens for refractory acute myeloid leukaemia
|
Majhail, Navneet S
|
|
2015
|
2 |
9 |
p. e354-e355
nvt p.
|
artikel
|
| 3 |
Cyclophosphamide conditioning in patients with severe aplastic anaemia given unrelated marrow transplantation: a phase 1–2 dose de-escalation study
|
Anderlini, Paolo
|
|
2015
|
2 |
9 |
p. e367-e375
nvt p.
|
artikel
|
| 4 |
De-escalation of treatment for acute promyelocytic leukaemia?
|
Mathews, Vikram
|
|
2015
|
2 |
9 |
p. e348-e349
nvt p.
|
artikel
|
| 5 |
Fix My Genes
|
Smith, Lan-Lan
|
|
2015
|
2 |
9 |
p. e356-
1 p.
|
artikel
|
| 6 |
Outcomes after use of two standard ablative regimens in patients with refractory acute myeloid leukaemia: a retrospective, multicentre, registry analysis
|
Nagler, Arnon
|
|
2015
|
2 |
9 |
p. e384-e392
nvt p.
|
artikel
|
| 7 |
Ponatinib as first-line treatment for patients with chronic myeloid leukaemia in chronic phase: a phase 2 study
|
Jain, Preetesh
|
|
2015
|
2 |
9 |
p. e376-e383
nvt p.
|
artikel
|
| 8 |
Ponatinib in chronic myeloid leukaemia: ready for first-line?
|
Breccia, Massimo
|
|
2015
|
2 |
9 |
p. e352-e353
nvt p.
|
artikel
|
| 9 |
Sweet spot for cyclophosphamide: a balancing act
|
Kulasekararaj, Austin G
|
|
2015
|
2 |
9 |
p. e350-e351
nvt p.
|
artikel
|
| 10 |
Use of arsenic trioxide in remission induction and consolidation therapy for acute promyelocytic leukaemia in the Australasian Leukaemia and Lymphoma Group (ALLG) APML4 study: a non-randomised phase 2 trial
|
Iland, Harry J
|
|
2015
|
2 |
9 |
p. e357-e366
nvt p.
|
artikel
|
Tijdschrift beschrijving